Proteomic-based stemness score measures oncogenic dedifferentiation and enables the identification of druggable targets.
Kołodziejczak-Guglas I, Simões RLS, de Souza Santos E, Demicco EG, Lazcano Segura RN, Ma W, Wang P, Geffen Y, Storrs E, Petralia F, Colaprico A, da Veiga Leprevost F, Pugliese P, Ceccarelli M, Noushmehr H, Nesvizhskii AI, Kamińska B, Priebe W, Lubiński J, Zhang B, Lazar AJ, Kurzawa P, Mesri M, Robles AI; Clinical Proteomic Tumor Analysis Consortium; Ding L, Malta TM, Wiznerowicz M.
Kołodziejczak-Guglas I, et al. Among authors: kaminska b.
Cell Genom. 2025 Jun 11;5(6):100851. doi: 10.1016/j.xgen.2025.100851. Epub 2025 Apr 17.
Cell Genom. 2025.
PMID: 40250426
Free PMC article.